DE60138333D1
(de)
|
2000-03-14 |
2009-05-28 |
Unilever Nv |
Variabele Domänen der schweren Kette eines Antikörpers gegen menschliche Ernährungslipasen und deren Verwendungen
|
US7371849B2
(en)
|
2001-09-13 |
2008-05-13 |
Institute For Antibodies Co., Ltd. |
Methods of constructing camel antibody libraries
|
JP2005517674A
(ja)
*
|
2002-01-03 |
2005-06-16 |
フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー |
腫瘍の処置に有用な新規免疫コンジュゲート
|
CA2472927A1
(en)
|
2002-01-10 |
2003-07-17 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
A novel splice variant of myd88 and uses thereof
|
CA2505326A1
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
|
EP1558646A2
(de)
|
2002-11-08 |
2005-08-03 |
Ablynx N.V. |
Antikörper aus camelidae gegen interferon-gamma und ihre verwendungen
|
EP2390270A1
(de)
|
2003-01-10 |
2011-11-30 |
Ablynx N.V. |
Therapeutische Polypeptide, Homologe davon, Fragmente davon und Verwendung bei modulierender plättchenvermittelter Aggregation
|
PT1687338E
(pt)
|
2003-11-07 |
2011-01-20 |
Ablynx Nv |
Anticorpos de domínio único vhh de camelídeos direccionados para o receptor do factor de crescimento epidérmico e suas utilizações
|
US7785903B2
(en)
|
2004-04-09 |
2010-08-31 |
Genentech, Inc. |
Variable domain library and uses
|
RU2401842C2
(ru)
|
2004-10-08 |
2010-10-20 |
Домантис Лимитед |
Антагонисты и способы их применения
|
DE602006015281D1
(de)
|
2005-01-14 |
2010-08-19 |
Ablynx Nv |
Verfahren und testvorrichtungen zur unterscheidung verschiedener formen von krankheiten und leiden, die durch thrombocytopenia und/oder durch spontane interaktionen zwischen dem von-willebrand-faktor und plättchen gekennzeichnet sind
|
MX2007014359A
(es)
|
2005-05-18 |
2008-02-06 |
Ablynx Nv |
Nanobodiestm (nanocuerpos) mejorados contra el factor alfa de necrosis del tumor.
|
SI2444424T1
(sl)
|
2005-05-20 |
2018-10-30 |
Ablynx N.V. |
Izboljšana protitelesa (TM) za zdravljenje z agregacijo posredovanih motenj
|
EP1983823A1
(de)
|
2006-01-17 |
2008-10-29 |
VIB vzw |
Hemmer der prolyl-hydroxylase 1 für die behandlung von skelettmuskeldegeneration
|
TWI417301B
(zh)
|
2006-02-21 |
2013-12-01 |
Wyeth Corp |
對抗人類介白素-22(il-22)之抗體及其用途
|
TW200744634A
(en)
|
2006-02-21 |
2007-12-16 |
Wyeth Corp |
Methods of using antibodies against human IL-22
|
US8703136B2
(en)
|
2006-10-10 |
2014-04-22 |
Regenesance B.V. |
Complement inhibition for improved nerve regeneration
|
GB0621513D0
(en)
|
2006-10-30 |
2006-12-06 |
Domantis Ltd |
Novel polypeptides and uses thereof
|
US8173423B2
(en)
|
2006-11-07 |
2012-05-08 |
Vib Vzw |
Diagnosis and treatment of T-cell acute lymphoblastic leukemia
|
EP2121743B1
(de)
|
2006-11-22 |
2015-06-03 |
Bristol-Myers Squibb Company |
Gezielte therapeutika auf der basis von manipulierten proteinen für tyrosinkinaserezeptoren, einschliesslich igf-ir
|
WO2008074840A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
|
US20100062004A1
(en)
|
2006-12-19 |
2010-03-11 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
WO2008118013A2
(en)
|
2007-03-23 |
2008-10-02 |
To-Bbb Holding B.V. |
Targeted intracellular delivery of antiviral agents
|
AU2008270274B2
(en)
|
2007-07-03 |
2012-06-28 |
Ablynx N.V. |
Providing improved immunoglobulin sequences by mutating CDR and/or FR positions
|
EP3305324A1
(de)
|
2007-11-02 |
2018-04-11 |
Novartis AG |
Moleküle und verfahren zur modulation eines lipoproteinrezeptorassoziierten proteins 6 (lrp6) mit geringer dichte
|
AU2008328779B2
(en)
|
2007-11-27 |
2014-06-05 |
Ablynx N.V. |
Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
|
GB0800277D0
(en)
|
2008-01-08 |
2008-02-13 |
Imagination Tech Ltd |
Video motion compensation
|
GB2470328A
(en)
|
2008-03-05 |
2010-11-17 |
Ablynx Nv |
Novel antigen binding dimer complexes, methods of making and uses thereof
|
KR101568042B1
(ko)
|
2008-03-31 |
2015-11-10 |
가부시끼가이샤 히다치 세이사꾸쇼 |
감쇠력 조정식 완충기
|
GB0809069D0
(en)
|
2008-05-19 |
2008-06-25 |
Univ Leuven Kath |
Gene signatures
|
CN102056945A
(zh)
|
2008-04-07 |
2011-05-11 |
埃博灵克斯股份有限公司 |
针对Notch途径的单可变结构域
|
JP2011516603A
(ja)
|
2008-04-17 |
2011-05-26 |
アブリンクス エン.ヴェー. |
血清タンパク質と結合することが可能なペプチド、並びにこれを含む化合物、構築物及びポリペプチド
|
KR20110020825A
(ko)
|
2008-05-16 |
2011-03-03 |
아블린쓰 엔.브이. |
Cxcr4 및 다른 gpcr에 대해 유도된 아미노산 서열 및 이를 포함하는 화합물
|
CN102099373A
(zh)
|
2008-05-22 |
2011-06-15 |
百时美施贵宝公司 |
基于纤连蛋白的多价支架结构域蛋白
|
EP2344180A2
(de)
|
2008-09-23 |
2011-07-20 |
Wyeth LLC |
Verfahren zur vorhersage der produktion von aktivierenden signalen durch vernetzende bindungsproteine
|
GB0900425D0
(en)
|
2009-01-12 |
2009-02-11 |
Ucb Pharma Sa |
Biological products
|
US9085795B2
(en)
|
2009-02-04 |
2015-07-21 |
Molecular Innovations, Inc. |
Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin and antibodies
|
EP2403873A1
(de)
|
2009-03-05 |
2012-01-11 |
Ablynx N.V. |
Neue antigenbindende dimerkomplexe, verfahren zur herstellung/vermeidung und anwendungen davon
|
AU2010243551B2
(en)
|
2009-04-30 |
2015-03-26 |
Ablynx Nv |
Method for the production of domain antibodies
|
JP2012531212A
(ja)
|
2009-07-03 |
2012-12-10 |
アビペップ ピーティーワイ リミテッド |
イムノコンジュゲート及びその作製方法
|
BR112012000536A2
(pt)
|
2009-07-08 |
2020-08-11 |
Kymab Limited |
métodos para produção de anticorpo ou cadeia leve ou pesada de anticorpo específico para um antígeno desejado, para produção de anticorpo ou cadeia de anticorpo e seu uso, composição farmacêutica e derivado de anticorpo quimérico
|
US20120204278A1
(en)
|
2009-07-08 |
2012-08-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
WO2011003622A1
(en)
|
2009-07-10 |
2011-01-13 |
Ablynx N.V. |
Method for the production of variable domains
|
US20120230918A1
(en)
|
2009-07-28 |
2012-09-13 |
Hoffmann-La-Roche Inc. |
Non-invasive in vivo optical imaging method
|
JP5962996B2
(ja)
|
2009-09-03 |
2016-08-03 |
キャンサー・リサーチ・テクノロジー・リミテッド |
Clec14a阻害剤
|
PT2473528E
(pt)
|
2009-09-03 |
2015-03-04 |
Ablynx Nv |
Formulações estáveis de polipéptidos e seus usos
|
GB0922434D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucb Pharma Sa |
antibodies and fragments thereof
|
GB0922435D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucb Pharma Sa |
Method
|
CN102781963B
(zh)
|
2009-10-27 |
2018-02-16 |
Ucb医药有限公司 |
功能修饰性NAv1.7抗体
|
US9234037B2
(en)
|
2009-10-27 |
2016-01-12 |
Ucb Biopharma Sprl |
Method to generate antibodies to ion channels
|
EP2516462B1
(de)
|
2009-12-23 |
2015-05-06 |
Avipep Pty Ltd |
Immunkonjugate und verfahren zu ihrer herstellung
|
WO2011083141A2
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Method for generation of immunoglobulin sequences by using lipoprotein particles
|
AU2011212442A1
(en)
|
2010-02-05 |
2012-08-09 |
Ablynx Nv |
Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
|
JP5951508B2
(ja)
|
2010-02-11 |
2016-07-13 |
アブリンクス エン.ヴェー. |
エアロゾルの調製のための方法及び組成物
|
EP2553449A2
(de)
|
2010-03-26 |
2013-02-06 |
Westfälische Wilhelms-Universität Münster |
Ersatztherapie für glucocorticoide
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
US9556273B2
(en)
|
2010-03-29 |
2017-01-31 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
WO2013174537A1
(en)
|
2012-05-24 |
2013-11-28 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
GB201105584D0
(en)
|
2011-04-01 |
2011-05-18 |
Imp Innovations Ltd |
Cancer methods
|
EP2567234B1
(de)
|
2010-05-07 |
2018-09-19 |
F.Hoffmann-La Roche Ag |
Diagnoseverfahren zum Nachweis von Zellen ex vivo
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
US20130149297A1
(en)
|
2010-07-02 |
2013-06-13 |
Vib Vzw |
Role of fragile x mental retardation gene and protein in cancer metastasis
|
GB201012845D0
(en)
|
2010-07-30 |
2010-09-15 |
Vib Vzw |
Inhibition of dicer function for treatment of cancer
|
US20120244141A1
(en)
|
2010-09-28 |
2012-09-27 |
Boehringer Ingelheim International Gmbh |
Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
|
US20130261288A1
(en)
|
2010-10-29 |
2013-10-03 |
Ablynx N.V. |
Method for the production of immunoglobulin single variable domains
|
GB201018602D0
(en)
*
|
2010-11-04 |
2010-12-22 |
Vib Vzw |
MMP8 inactivating antigen binding proteins
|
EP2683413A1
(de)
|
2011-03-07 |
2014-01-15 |
F.Hoffmann-La Roche Ag |
In-vivo-auswahl therapeutisch aktiver antikörper
|
EP2683290B1
(de)
|
2011-03-07 |
2018-11-07 |
F.Hoffmann-La Roche Ag |
Verfahren zum in-vivo-testen von therapeutischen antikörpern
|
US9624294B2
(en)
|
2011-03-14 |
2017-04-18 |
Cellmid Limited |
Antibody recognizing N-domain of midkine
|
EP2691415B1
(de)
|
2011-03-28 |
2018-07-11 |
Ablynx N.V. |
Verfahren zur herstellung fester formulierungen mit variablen immunglobulin-einzeldomänen
|
EP3590950A1
(de)
|
2011-05-09 |
2020-01-08 |
Ablynx NV |
Verfahren zur herstellung von einzelvariablen immunglobulindomänen
|
AU2012264809B2
(en)
|
2011-05-27 |
2017-05-04 |
Ablynx Nv |
Inhibition of bone resorption with RANKL binding peptides
|
WO2012166906A1
(en)
|
2011-05-31 |
2012-12-06 |
Massachusetts Institute Of Technology |
Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
|
US9193793B2
(en)
|
2011-06-13 |
2015-11-24 |
Csl Limited |
Antibodies against G-CSFR and uses thereof
|
IN2014CN00437A
(de)
|
2011-06-23 |
2015-04-03 |
Ablynx Nv |
|
GB201112056D0
(en)
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
GB201115529D0
(en)
|
2011-09-08 |
2011-10-26 |
Imp Innovations Ltd |
Antibodies, uses and methods
|
AU2012311286B2
(en)
|
2011-09-19 |
2018-07-26 |
Kymab Limited |
Antibodies, variable domains and chains tailored for human use
|
DK2747782T3
(en)
|
2011-09-23 |
2018-04-23 |
Ablynx Nv |
Long-term inhibition of interleukin-6-mediated signal transmission
|
EP2771351B1
(de)
|
2011-10-28 |
2017-06-14 |
Patrys Limited |
Pat-lm1-epitope und verfahren zu ihrer verwendung
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
WO2013079973A1
(en)
|
2011-12-02 |
2013-06-06 |
Di Cara Danielle Marie |
Antibodies against hgf - receptor and uses
|
EP2809800A1
(de)
|
2012-01-30 |
2014-12-10 |
VIB vzw |
Mittel und verfahren zur diagnose und behandlung von morbus alzheimer
|
WO2013121042A1
(en)
|
2012-02-16 |
2013-08-22 |
Vib Vzw |
PP2A SUBUNITS IN DNA REPAIR, THE PP2A B55α SUBUNIT AS NOVEL PHD2 INTERACTING PROTEIN, AND IMPLICATIONS FOR CANCER
|
US10251377B2
(en)
|
2012-03-28 |
2019-04-09 |
Kymab Limited |
Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
|
GB2502127A
(en)
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
US11339208B1
(en)
|
2012-05-31 |
2022-05-24 |
United States Of America As Represented By The Secretary Of The Air Force |
Camelidae single-domain antibodies against Yersinia pestis and methods of use
|
WO2014001557A1
(en)
|
2012-06-28 |
2014-01-03 |
Ucb Pharma S.A. |
A method for identifying compounds of therapeutic interest
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
EP2951201B1
(de)
|
2013-01-30 |
2017-10-18 |
VIB vzw |
Stabilisierung von konformationsspezifischen gpcrs und verwendung in der arzneimittelsuche.
|
ES2745772T3
(es)
|
2013-02-05 |
2020-03-03 |
Vib Vzw |
Agentes de unión al receptor muscarínico de la acetilcolina y usos de los mismos
|
WO2014121325A1
(en)
|
2013-02-07 |
2014-08-14 |
Csl Limited |
Il-11r binding proteins and uses thereof
|
AU2014229952B2
(en)
|
2013-03-15 |
2018-10-04 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases
|
WO2014144292A2
(en)
|
2013-03-15 |
2014-09-18 |
Sanofi Pasteur Biologics , Llc |
Antibodies against clostridium difficile toxins and methods of using the same
|
US9788534B2
(en)
|
2013-03-18 |
2017-10-17 |
Kymab Limited |
Animal models and therapeutic molecules
|
EP3597758A1
(de)
|
2013-04-29 |
2020-01-22 |
AgroSavfe nv |
Agrochemische zusammensetzungen mit polypeptiden
|
US11707056B2
(en)
|
2013-05-02 |
2023-07-25 |
Kymab Limited |
Animals, repertoires and methods
|
US9783593B2
(en)
|
2013-05-02 |
2017-10-10 |
Kymab Limited |
Antibodies, variable domains and chains tailored for human use
|
NL1040254C2
(en)
|
2013-05-17 |
2014-11-24 |
Ablynx Nv |
Stable formulations of immunoglobulin single variable domains and uses thereof.
|
CN105683365A
(zh)
|
2013-10-01 |
2016-06-15 |
科马布有限公司 |
动物模型及治疗分子
|
US9803008B2
(en)
|
2013-11-28 |
2017-10-31 |
Csl Limited |
Method of treating diabetic nephropathy by administering antibodies to vascular endothelial growth factor B (VEGF-B)
|
EP2883883A1
(de)
|
2013-12-16 |
2015-06-17 |
Cardio3 Biosciences S.A. |
Therapeutische Ziele und Mittel zur Behandlung von ischämiebedingten Reperfusionsschäden
|
US9045545B1
(en)
|
2014-07-15 |
2015-06-02 |
Kymab Limited |
Precision medicine by targeting PD-L1 variants for treatment of cancer
|
US9914769B2
(en)
|
2014-07-15 |
2018-03-13 |
Kymab Limited |
Precision medicine for cholesterol treatment
|
US8992927B1
(en)
|
2014-07-15 |
2015-03-31 |
Kymab Limited |
Targeting human NAV1.7 variants for treatment of pain
|
US9067998B1
(en)
|
2014-07-15 |
2015-06-30 |
Kymab Limited |
Targeting PD-1 variants for treatment of cancer
|
US8986694B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Targeting human nav1.7 variants for treatment of pain
|
BR112016014099A2
(pt)
|
2013-12-18 |
2017-10-10 |
B Creative Sweden Ab |
método de tratamento de feridas
|
AU2015217846B2
(en)
|
2014-01-30 |
2019-10-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Opioid receptor binding agents and uses thereof
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
US9139648B1
(en)
|
2014-07-15 |
2015-09-22 |
Kymab Limited |
Precision medicine by targeting human NAV1.9 variants for treatment of pain
|
DK3194976T3
(da)
|
2014-07-22 |
2020-07-13 |
Vib Vzw |
Fremgangsmåder til udvælgelse af midler, som stabiliserer proteinkomplekser
|
WO2016016329A1
(en)
|
2014-07-29 |
2016-02-04 |
Vrije Universiteit Brussel |
Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response
|
EP3174559B1
(de)
|
2014-07-29 |
2022-10-19 |
Vrije Universiteit Brussel |
Radioaktiv markierte antikörperfragmente zur verwendung bei der vorbeugung und/oder der behandlung von krebs
|
WO2016061632A1
(en)
|
2014-10-23 |
2016-04-28 |
La Trobe University |
Fn14-binding proteins and uses thereof
|
US10858666B2
(en)
|
2014-11-05 |
2020-12-08 |
Biotalys |
Transgenic plants expressing a variable domain of a heavy chain antibody (VHH) that binds to a sphingolipid of a fungus
|
US11426468B2
(en)
|
2014-12-19 |
2022-08-30 |
Ablynx N.V. |
Cysteine linked nanobody dimers
|
US10940212B2
(en)
|
2014-12-19 |
2021-03-09 |
Monash University |
IL-21 agonist antibodies and methods of treatment using same
|
GB201501004D0
(en)
|
2015-01-21 |
2015-03-04 |
Cancer Rec Tech Ltd |
Inhibitors
|
BR112018000672A2
(pt)
|
2015-07-17 |
2018-09-18 |
Univ Brussel Vrije |
fragmentos de anticorpo radiomarcados para uso no tratamento de câncer
|
CN105384825B
(zh)
|
2015-08-11 |
2018-06-01 |
南京传奇生物科技有限公司 |
一种基于单域抗体的双特异性嵌合抗原受体及其应用
|
US11248055B2
(en)
|
2015-11-27 |
2022-02-15 |
Ablynx N.V. |
Polypeptides inhibiting CD40L
|
US10829562B2
(en)
|
2015-12-10 |
2020-11-10 |
Katholieke Universiteit Leuven |
Haemorrhagic disorder due to ventricular assist device
|
WO2017182605A1
(en)
|
2016-04-22 |
2017-10-26 |
Université Libre de Bruxelles |
A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
US11243214B2
(en)
|
2016-04-22 |
2022-02-08 |
Université Libre de Bruxelles |
Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
JP2019523213A
(ja)
|
2016-05-02 |
2019-08-22 |
アブリンクス エン.ヴェー. |
Rsv感染の処置
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
WO2018014260A1
(en)
|
2016-07-20 |
2018-01-25 |
Nanjing Legend Biotech Co., Ltd. |
Multispecific antigen binding proteins and methods of use thereof
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
WO2018050833A1
(en)
|
2016-09-15 |
2018-03-22 |
Ablynx Nv |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
JP7051826B2
(ja)
|
2016-09-23 |
2022-04-11 |
シーエスエル、リミテッド |
凝固因子結合タンパク質及びその使用
|
WO2018068201A1
(en)
|
2016-10-11 |
2018-04-19 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against ctla-4
|
EP3534947A1
(de)
|
2016-11-03 |
2019-09-11 |
Kymab Limited |
Antikörper, kombinationen mit antikörpern, biomarker, verwendungen und verfahren
|
CN117700549A
(zh)
|
2016-11-16 |
2024-03-15 |
埃博灵克斯股份有限公司 |
能够结合CD123和TCRα/β的T细胞募集多肽
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
KR102616335B1
(ko)
|
2017-02-28 |
2023-12-21 |
브이아이비 브이지더블유 |
경구 단백질 전달을 위한 수단 및 방법
|
CA3058290A1
(en)
|
2017-04-18 |
2018-10-25 |
Universite Libre De Bruxelles |
Biomarkers and targets for proliferative diseases
|
US11891451B2
(en)
|
2017-05-11 |
2024-02-06 |
Vib Vzw |
Glycosylation of variable immunoglobulin domains
|
EP4272822A3
(de)
|
2017-06-02 |
2024-03-27 |
Merck Patent GmbH |
Adamts-bindende immunoglobuline
|
SG10202113337YA
(en)
|
2017-06-02 |
2021-12-30 |
Ablynx Nv |
Aggrecan binding immunoglobulins
|
JP7249961B2
(ja)
|
2017-06-02 |
2023-03-31 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Adamts5、mmp13およびアグリカンに結合するポリペプチド
|
KR20200015601A
(ko)
|
2017-06-02 |
2020-02-12 |
메르크 파텐트 게엠베하 |
Mmp13 결합성 면역글로불린
|
GB201709379D0
(en)
|
2017-06-13 |
2017-07-26 |
Univ Leuven Kath |
Humanised ADAMTS13 binding antibodies
|
WO2019000223A1
(en)
|
2017-06-27 |
2019-01-03 |
Nanjing Legend Biotech Co., Ltd. |
ENABLERS OF IMMUNE EFFECTOR CELLS OF CHIMERIC ANTIBODIES AND METHODS OF USE THEREOF
|
WO2019014360A1
(en)
|
2017-07-11 |
2019-01-17 |
Alexion Pharmaceuticals, Inc. |
POLYPEPTIDES BINDING COMPONENT C5 OR SERUM ALBUMIN COMPONENT AND FUSION PROTEINS THEREOF
|
CA3070253A1
(en)
|
2017-07-19 |
2019-01-24 |
Vib Vzw |
Serum albumin binding agents
|
WO2019016784A1
(en)
|
2017-07-21 |
2019-01-24 |
Universidade De Coimbra |
ANTI-NUCLEOLIN ANTIBODIES
|
US20200354452A1
(en)
|
2017-09-29 |
2020-11-12 |
City Of Hope |
Cars and bispecific antibodies for treatment of mantle cell lymphoma
|
EP3697812A4
(de)
|
2017-10-18 |
2021-09-22 |
CSL Limited |
Menschliche serumalbuminvarianten und ihre verwendungen
|
CA3076791A1
(en)
|
2017-10-31 |
2019-05-09 |
Vib Vzw |
Novel antigen-binding chimeric proteins and methods and uses thereof
|
US10017560B1
(en)
|
2017-11-16 |
2018-07-10 |
King Saud University |
Nanobody against begomoviruses
|
JP7465210B2
(ja)
|
2017-11-29 |
2024-04-10 |
シーエスエル リミティド |
虚血-再灌流障害の治療又は予防方法
|
JP2021505208A
(ja)
|
2017-12-05 |
2021-02-18 |
セリアド エス.アー.Celyad S.A. |
養子細胞療法用細胞の持続性を向上するための組成物および方法
|
EP3720950A1
(de)
|
2017-12-05 |
2020-10-14 |
Celyad S.A. |
Reduzierung des fratrizids von immunzellen, die nkg2d-basierte rezeptoren exprimieren
|
CN111699198B
(zh)
|
2017-12-28 |
2023-09-05 |
南京传奇生物科技有限公司 |
针对tigit的单域抗体和其变体
|
EP3740507A4
(de)
|
2018-01-15 |
2022-08-24 |
Nanjing Legend Biotech Co., Ltd. |
Einzeldomänenantikörper und varianten davon gegen pd-1
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
WO2019166622A1
(en)
|
2018-03-01 |
2019-09-06 |
Vrije Universiteit Brussel |
Human pd-l1-binding immunoglobulins
|
WO2019180204A1
(en)
|
2018-03-23 |
2019-09-26 |
Université Libre de Bruxelles |
Wnt signaling agonist molecules
|
AU2019241439A1
(en)
|
2018-03-27 |
2020-10-22 |
Umc Utrecht Holding B.V. |
Targeted thrombolysis for treatment of microvascular thrombosis
|
KR20200138720A
(ko)
|
2018-03-30 |
2020-12-10 |
난징 레전드 바이오테크 씨오., 엘티디. |
Lag-3에 대한 단일-도메인 항체 및 이의 용도
|
US20210221864A1
(en)
|
2018-08-24 |
2021-07-22 |
City Of Hope |
Masked cytokine conjugates
|
GB201814451D0
(en)
|
2018-09-05 |
2018-10-17 |
Valerie Nicholas Carl Kristoffer |
Methods
|
US20220276244A1
(en)
|
2019-04-29 |
2022-09-01 |
Confo Therapeutics N.V. |
Chimeric proteins and methods to screen for compounds and ligands binding to gpcrs
|
WO2020221888A1
(en)
|
2019-04-30 |
2020-11-05 |
Vib Vzw |
Cystic fibrosis transmembrane conductance regulator stabilizing agents
|
EP3976067A1
(de)
|
2019-05-28 |
2022-04-06 |
Vib Vzw |
Cd8+-t-zellen ohne plexine und ihre anwendung zur krebsbehandlung
|
EP3976650A1
(de)
|
2019-05-28 |
2022-04-06 |
Vib Vzw |
Krebsbehandlung durch abzielen auf plexine im immunbereich
|
GB2584441A
(en)
|
2019-06-03 |
2020-12-09 |
Fenomark Diagnostics Ab |
Medical uses, methods and uses
|
JP7171737B2
(ja)
*
|
2019-07-23 |
2022-11-15 |
源道隆(蘇州)医学科技有限公司 |
Sftsvに結合可能なナノ抗体及びその使用
|
WO2021078786A1
(en)
|
2019-10-21 |
2021-04-29 |
Vib Vzw |
Nanodisc-specific antigen-binding chimeric proteins
|
MX2022005678A
(es)
|
2019-11-11 |
2022-10-18 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanocuerpos para el control de insectos y usos de los mismos.
|
EP4065603A1
(de)
|
2019-11-27 |
2022-10-05 |
Vib Vzw |
Positive allosterische modulatoren des calciumempfindlichen rezeptors
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
EP4077372A1
(de)
|
2019-12-20 |
2022-10-26 |
Vib Vzw |
Nanokörperaustauschchromatographie
|
WO2021119761A1
(en)
|
2019-12-20 |
2021-06-24 |
Hudson Institute of Medical Research |
Cxcl10 binding proteins and uses thereof
|
WO2021140205A1
(en)
|
2020-01-10 |
2021-07-15 |
Confo Therapeutics N.V. |
Methods for generating antibodies and antibody fragments and libraries comprising same
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
EP4110794A1
(de)
|
2020-02-25 |
2023-01-04 |
Vib Vzw |
Allosterische modulatoren der leucinreichen repeat-kinase 2
|
JP2023519975A
(ja)
|
2020-03-31 |
2023-05-15 |
バイオタリス・エン・フェー |
抗真菌ポリペプチド
|
CN113527488A
(zh)
|
2020-04-22 |
2021-10-22 |
迈威(上海)生物科技股份有限公司 |
一种靶向人程序性死亡配体1(pd-l1)的单可变域抗体及其衍生物
|
WO2021229104A1
(en)
|
2020-05-15 |
2021-11-18 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
WO2022003156A1
(en)
|
2020-07-02 |
2022-01-06 |
Oncurious Nv |
Ccr8 non-blocking binders
|
EP4189060A1
(de)
|
2020-07-31 |
2023-06-07 |
Biotalys NV |
Expressionswirt
|
WO2022035998A1
(en)
|
2020-08-11 |
2022-02-17 |
City Of Hope |
Compositions and uses of sars-cov-2 targeted chimeric antigen receptor modified nk cells
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
EP4216943A1
(de)
|
2020-09-24 |
2023-08-02 |
Vib Vzw |
Kombination von p2y6-inhibitoren und immuncheckpoint-inhibitoren
|
US20220153854A1
(en)
|
2020-09-25 |
2022-05-19 |
Ablynx N.V. |
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and ox40l
|
US20240018248A1
(en)
|
2020-12-02 |
2024-01-18 |
Vib Vzw |
An ltbr agonist in combination therapy against cancer
|
WO2022117569A1
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
|
US11897951B2
(en)
|
2020-12-18 |
2024-02-13 |
Ablynx N.V. |
Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-α
|
GB202020502D0
(en)
|
2020-12-23 |
2021-02-03 |
Vib Vzw |
Antibody composistion for treatment of corona virus infection
|
CA3206125A1
(en)
|
2020-12-24 |
2022-06-30 |
Vib Vzw |
Murine cross-reactive human ccr8 binders
|
EP4267618A1
(de)
|
2020-12-24 |
2023-11-01 |
Vib Vzw |
Nichtblockierende, menschliche ccr8-bindemittel
|
CA3206304A1
(en)
|
2020-12-24 |
2022-06-30 |
Vib Vzw |
Human ccr8 binders
|
GB2603166A
(en)
|
2021-01-29 |
2022-08-03 |
Thelper As |
Therapeutic and Diagnostic Agents and Uses Thereof
|
AU2022216460A1
(en)
|
2021-02-05 |
2023-09-21 |
Universiteit Gent |
Sarbecovirus binders
|
CN117794566A
(zh)
|
2021-02-05 |
2024-03-29 |
Vib研究所 |
沙贝病毒结合剂
|
EP4294407A1
(de)
|
2021-02-17 |
2023-12-27 |
Vib Vzw |
Hemmung von slc4a4 bei der behandlung von krebs
|
EP4294516A1
(de)
|
2021-02-19 |
2023-12-27 |
Vib Vzw |
Kationunabhängige mannose-6-phosphatrezeptorbindemittel
|
WO2022199804A1
(en)
|
2021-03-24 |
2022-09-29 |
Vib Vzw |
Nek6 inhibition to treat als and ftd
|
WO2022242892A1
(en)
|
2021-05-17 |
2022-11-24 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
CA3225194A1
(en)
|
2021-06-23 |
2022-12-29 |
Vib Vzw |
Means and methods for selection of specific binders
|
WO2023274183A1
(zh)
|
2021-06-29 |
2023-01-05 |
江苏先声药业有限公司 |
Cd16抗体及其应用
|
CN117751143A
(zh)
|
2021-07-30 |
2024-03-22 |
山东先声生物制药有限公司 |
抗pvrig/抗tigit双特异性抗体和应用
|
WO2023016828A2
(en)
|
2021-07-30 |
2023-02-16 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
WO2023023220A1
(en)
|
2021-08-20 |
2023-02-23 |
Alexion Pharmaceuticals, Inc. |
Methods for treating sickle cell disease or beta thalassemia using a complement alternative pathway inhibitor
|
WO2023023227A1
(en)
|
2021-08-20 |
2023-02-23 |
Alexion Pharmaceuticals, Inc. |
Methods for treating sickle cell disease or beta thalassemia using complement alternative pathway inhibitors
|
WO2023057601A1
(en)
|
2021-10-06 |
2023-04-13 |
Biotalys NV |
Anti-fungal polypeptides
|
EP4177266A1
(de)
|
2021-11-05 |
2023-05-10 |
Katholieke Universiteit Leuven |
Neutralisierende humane anti-sars-cov-2-antikörper
|
WO2023079137A1
(en)
|
2021-11-05 |
2023-05-11 |
Katholieke Universiteit Leuven |
Neutralizing anti-sars-cov-2 human antibodies
|
TW202342508A
(zh)
|
2021-12-17 |
2023-11-01 |
比利時商艾伯霖克斯公司 |
包含靶向TCRαβ、CD33和CD123的免疫球蛋白單可變結構域的多肽
|
WO2023135198A1
(en)
|
2022-01-12 |
2023-07-20 |
Vib Vzw |
Human ntcp binders for therapeutic use and liver-specific targeted delivery
|
GB202201137D0
(en)
|
2022-01-28 |
2022-03-16 |
Thelper As |
Therapeutic and diagnostic agents and uses thereof
|
WO2023148291A1
(en)
|
2022-02-02 |
2023-08-10 |
Biotalys NV |
Methods for genome editing
|
WO2023148397A1
(en)
|
2022-02-07 |
2023-08-10 |
Vib Vzw |
Engineered stabilizing aglycosylated fc-regions
|
WO2023198848A1
(en)
|
2022-04-13 |
2023-10-19 |
Vib Vzw |
An ltbr agonist in combination therapy against cancer
|
WO2023213751A1
(en)
|
2022-05-02 |
2023-11-09 |
Umc Utrecht Holding B.V |
Single domain antibodies for the detection of plasmin-cleaved vwf
|
WO2023222825A1
(en)
|
2022-05-18 |
2023-11-23 |
Vib Vzw |
Sarbecovirus spike s2 subunit binders
|
WO2024008755A1
(en)
|
2022-07-04 |
2024-01-11 |
Vib Vzw |
Blood-cerebrospinal fluid barrier crossing antibodies
|
WO2024008904A2
(en)
|
2022-07-08 |
2024-01-11 |
Novo Nordisk A/S |
Highly potent isvd compounds capable of substituting for fviii(a)
|
WO2024049951A1
(en)
|
2022-08-31 |
2024-03-07 |
Alexion Pharmaceuticals, Inc. |
Dosage and administration of fusion polypeptides for treatment of sickle cell disease
|
WO2024068744A1
(en)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antivirals against human parainfluenza virus
|